Autres langues ABIONYX Pharma Börse Stuttgart

Actions

609 FR0012616852

Marché Fermé - Börse Stuttgart Autres places de cotation 15:36:53 02/07/2024			Varia. 5j.	Varia. 1 janv.
1,136 ^EUR	+0,71%		-1,22%	-36,96%

01/07	Abionyx Pharma : succès de l'augmentation de capital	CF
01/07	ABIONYX Pharma : réussit une augmentation de capital, visibilité jusqu'à fin 2025	AO

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Abionyx Pharma : succès de l'augmentation de capital	01/07
ABIONYX Carries out Successfully a Capital Increase With Cancellation of Preferential Subscription Rights for the Benefit of a Category of Persons Through the Issue of Shares With Warrants for an Amount of c.€3.4 Million	01/07
ABIONYX Pharma announces unanimous approval of all resolutions put to the vote at its Combined General Meeting	27/06
Borsa di Italia: Un'altra valanga di banchieri centrali	20/06
Bolsa de Madrid: Otra avalancha de banqueros centrales	20/06
ABIONYX decides on a capital increase with cancellation of preferential subscription rights for the benefit of a category of persons through the issue of shares with warrants for an amount of c.€3.4 million	19/06
Abionyx : retour favorable de la FDA, le titre monte	14/06
ABIONYX Pharma : has completed a successful pre IND meeting with the FDAfor CER 001 Phase 2b/3 Clinical Trial for Patients with Sepsis	13/06
ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis	13/06
ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis	13/06
ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis	13/06
ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 1st Quarter 2024	16/05
ABIONYX Pharma: Availability of the Universal Registration Document for the Year 2023	02/05
Abionyx Pharma : va bénéficier d'une aide de 1ME de Bpifrance	14/03
ABIONYX Pharma - Bpifrance Supports the Development of CER-001 in Ophthalmology With a Nearly €1 Million Non-dilutive Innovation Grant	14/03
Abionyx : réduction de la perte nette en 2023	11/03
ABIONYX Pharma Announces Its 2023 Full-Year Financial Results	11/03
ABIONYX Pharma SA Reports Earnings Results for the Full Year Ended December 31, 2023	11/03
ABIONYX Pharma announces its financial calendar for the year 2024	07/03
Abionyx : échec de CSL Behring dans les maladies cardiaques	16/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ABIONYX Pharma Börse Stuttgart

Actions

609

FR0012616852

Autres langues

Filtres